Pharcos Specialty Ltd., a leader in specialty chemicals and excipients, has introduced Pharcocel, India’s first locally manufactured Hydroxypropyl Methylcellulose (HPMC) excipient. This innovation marks a transformative moment in the Indian pharmaceutical manufacturing landscape, elevating India’s global standing in excipient production.
With its launch at a cutting-edge manufacturing facility in Daman, Pharcocel makes Pharcos:
This initiative directly supports the ‘Make in India’ mission, promoting self-reliance and reducing import dependency in the pharmaceutical sector.
Pharcocel is a cellulose ether excipient designed for broad utility across pharmaceutical, nutraceutical, and industrial applications. Available in viscosities ranging from 3 cps to 200,000 cps, it supports various formulations including:
Its adaptability empowers formulators to develop precise, effective, and consistent dosage forms.
Pharcos’ HPMC manufacturing facility adheres to internationally recognized standards, ensuring product safety, quality, and global market compatibility:
These credentials reflect Pharcos’ unwavering commitment to excellence and regulatory compliance.
The launch of Pharcocel is more than a product milestone—it is a strategic leap for India’s excipient capabilities. It transitions India from being primarily a volume-based supplier to a value-driven, innovation-led contributor in the global pharmaceutical value chain.
With a legacy of over 45 years, Pharcos operates:
The company’s R&D and QA departments are equipped with state-of-the-art laboratories and systems aligned with international regulatory expectations.
Chairman Vijay Doshi outlines Pharcos’ long-term vision:
“Our vision is to transform India from a low-cost supplier to a high-value, innovation-led global pharma leader. We believe innovation thrives on collaboration, and our clients are co-creators in delivering sustainable, scalable, and efficient solutions.”
Key strategic pillars include:
Pharcocel marks a new era for India’s pharmaceutical excipient industry. Backed by Pharcos’ deep industry experience, cutting-edge technology, and visionary leadership, it not only enhances India’s self-reliance but also positions the country as a competitive player in the global pharmaceutical innovation landscape.